Fisher Scientific acquires PSS World Medical
Fisher Scientific has acquired specialty medical marketer and distributor PSS World Medical in a tax-free, stock-for-stock transaction valued at $840 million. Fisher supplies laboratory supplies and equipment, e-commerce technology, and other services to
Fisher Scientific has acquired specialty medical marketer and distributor PSS World Medical in a tax-free, stock-for-stock transaction valued at $840 million. Fisher supplies laboratory supplies and equipment, e-commerce technology, and other services to the scientific research community.
In February, PSS hired an investment banking firm to help its board of directors investigate ways to increase the value of its stock for shareholders. PSS has been looking for an acquisition partner since then, the company said. The company had built a presence in the medical imaging industry through acquisitions and distribution agreements.
In 1996, PSS acquired Diagnostic Imaging. Three years later, Diagnostic Imaging signed an agreement with Philips Medical Systems North America that gave DI exclusive distribution rights to Philips Tomoscan EG CT and BV25 Gold Mobile C-arm systems. Last month Diagnostic Imaging revised a distribution agreement with SonoSite, allowing other companiessuch as ATL Ultrasoundto include the SonoSite 180 handheld ultrasound system with sales of their own ultrasound systems (SCAN 6/7/00).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
